-
Resura is the First Prenatal Non-Invasive Test for Cystic Fibrosis
Resura, the first non-invasive prenatal test for single-gene disorders such as cystic fibrosis, has been launched by the biotech company Progenity. Learn more about Resura here.
What do you think the impact of Resura will be for the cystic fibrosis community?
Sorry, there were no replies found.
Log in to reply.